- Home
- Publications
- Publication Search
- Publication Details
Title
New strategies and perspectives on managing IgA nephropathy
Authors
Keywords
IgA nephropathy, Berger’s disease, Novel treatments, Repurposed therapy
Journal
Clinical and Experimental Nephrology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-13
DOI
10.1007/s10157-019-01700-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IgA nephropathy: toward more specific diagnosis (and rescue of snails)
- (2018) Jürgen Floege KIDNEY INTERNATIONAL
- Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases
- (2017) Eileen Samy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma
- (2017) John P. Leonard et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy
- (2017) Thomas Rauen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
- (2017) David R.W. Jayne et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mucosal corticosteroid therapy of IgA nephropathy
- (2017) Jürgen Floege KIDNEY INTERNATIONAL
- Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
- (2017) Bengt C Fellström et al. LANCET
- Immunosuppression in IgA Nephropathy: Guideline Medicine Versus Personalized Medicine
- (2017) John Feehally SEMINARS IN NEPHROLOGY
- Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date
- (2017) Aleksander Lenert et al. Drug Design Development and Therapy
- Immunoglobulin A nephropathy: a pathophysiology view
- (2016) Rafaela Cabral Gonçalves Fabiano et al. INFLAMMATION RESEARCH
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
- (2016) Richard A. Lafayette et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Epidemiology of Glomerular Disease in Southern Arizona
- (2016) Sangeetha Murugapandian et al. MEDICINE
- Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
- (2016) Ya-Ling Zhai et al. MEDICINE
- Con: STOP immunosuppression in IgA nephropathy
- (2016) Thomas Rauen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pro: STOP immunosuppression in IgA nephropathy?
- (2016) Claudio Pozzi NEPHROLOGY DIALYSIS TRANSPLANTATION
- Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy
- (2016) Yan Ouyang et al. PLoS One
- Smoking-Related Renal Histologic Injury in IgA Nephropathy Patients
- (2016) Yoon Jin Cha et al. YONSEI MEDICAL JOURNAL
- Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series
- (2016) Arvind Madan et al. BMC Nephrology
- Role of complement in IgA nephropathy
- (2015) Mohamed R. Daha et al. JOURNAL OF NEPHROLOGY
- Current Understanding of the Role of Complement in IgA Nephropathy
- (2015) N. Maillard et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression
- (2015) Stephen P. McAdoo et al. KIDNEY INTERNATIONAL
- Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis Study
- (2015) Caroline L Chembo et al. NEPHROLOGY
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leveraging Melanocortin Pathways to Treat Glomerular Diseases
- (2014) Rujun Gong ADVANCES IN CHRONIC KIDNEY DISEASE
- OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy
- (2014) Peter C Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of Body Mass Index on Progression of IgA Nephropathy Among Japanese Patients
- (2014) Mamiko Shimamoto et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- The Beneficial Effects of Weight Reduction in Overweight Patients With Chronic Proteinuric Immunoglobulin A Nephropathy: A Randomized Controlled Trial
- (2014) Piyawan Kittiskulnam et al. JOURNAL OF RENAL NUTRITION
- Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
- (2014) Rosanna Coppo et al. KIDNEY INTERNATIONAL
- TLR9 and BAFF: Their expression in patients with IgA nephropathy
- (2014) WEIWEI LI et al. Molecular Medicine Reports
- Pathology of IgA nephropathy
- (2014) Ian S. D. Roberts Nature Reviews Nephrology
- A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy
- (2014) T. Kawamura et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
- (2014) Junichiro Nakata et al. PLoS One
- Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
- (2014) Maria De Angelis et al. PLoS One
- C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA Nephropathy
- (2013) Lu Liu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease
- (2013) Sean J. Barbour et al. KIDNEY INTERNATIONAL
- Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy
- (2013) F. Berthoux et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- IgA Nephropathy
- (2013) Robert J. Wyatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis
- (2012) J. Cheng et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients
- (2012) M. J. Kim et al. JOURNAL OF IMMUNOLOGY
- Tonsillectomy and IgA nephritis
- (2012) Claudio Ponticelli NEPHROLOGY DIALYSIS TRANSPLANTATION
- Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis
- (2012) Krzysztof Kiryluk et al. PLoS Genetics
- Chapter 10: Immunoglobulin A nephropathy
- (2012) Kidney International Supplements
- Sodium-sensitive variability of the antiproteinuric efficacy of RAS inhibitors in outpatients with IgA nephropathy
- (2011) T. Suzuki et al. CLINICAL NEPHROLOGY
- Mice overexpressing BAFF develop a commensal flora–dependent, IgA-associated nephropathy
- (2011) Douglas D. McCarthy et al. JOURNAL OF CLINICAL INVESTIGATION
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population
- (2011) W. Le et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cigarette Smoking and Progression of IgA Nephropathy
- (2010) Ryohei Yamamoto et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Melanocortin 1 Receptor Agonists Reduce Proteinuria
- (2010) A. Lindskog et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials
- (2009) J. Cheng et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
- (2009) Ian S.D. Roberts et al. KIDNEY INTERNATIONAL
- Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy
- (2009) C. Manno et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Impact of Obesity on IgA Nephropathy: Comparative Ultrastructural Study between Obese and Non-Obese Patients
- (2009) Mari Tanaka et al. NEPHRON CLINICAL PRACTICE
- Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled Trial
- (2008) Jicheng Lv et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Tonsillectomy Plus Steroid Pulse Therapy on Clinical Remission of IgA Nephropathy: A Controlled Study
- (2008) H. Komatsu et al. Clinical Journal of the American Society of Nephrology
- Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy
- (2008) Rosanna Coppo et al. KIDNEY INTERNATIONAL
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial
- (2008) P. M. Ferraro et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Microbial IgA Protease Removes IgA Immune Complexes from Mouse Glomeruli In Vivo: Potential Therapy for IgA Nephropathy
- (2007) Michael E. Lamm et al. AMERICAN JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started